Document

https://cdn.kscope.io/5339ba6c3e993768208721e26772f622-image_0.jpghttps://cdn.kscope.io/5339ba6c3e993768208721e26772f622-image_0.jpg
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934
(Amendment No.    )
https://cdn.kscope.io/5339ba6c3e993768208721e26772f622-image_3.jpg

Filed by the Registrant     Filed by a Party other than the Registrant

Check the appropriate box:
☐    Preliminary Proxy Statement
☐    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐    Definitive Proxy Statement
    Definitive Additional Materials
☐    Soliciting Material under § 240.14a-12

PROCEPT BioRobotics Corporation
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):

    No fee required.

☐    Fee previously paid with preliminary materials.

☐    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.





https://cdn.kscope.io/5339ba6c3e993768208721e26772f622-noticefront.jpg



https://cdn.kscope.io/5339ba6c3e993768208721e26772f622-noticeback.jpg